Wealthspire Advisors (Maryland)’s Immune Design Corp. IMDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-6,500
Closed -$38K 2527
2019
Q1
$38K Buy
+6,500
New +$22.1K ﹤0.01% 1014

Wealthspire Advisors (Maryland)'s IMDZ Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 6,500 shares — an estimated $38K sold.

Wealthspire Advisors (Maryland) first reported a position in IMDZ in Q1 2019 and held it in 1 quarter. The position peaked at $38K in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 6,500 Immune Design Corp. shares in Q2 2019, an estimated $38K.
  • Wealthspire Advisors (Maryland) first reported a position in Immune Design Corp. in Q1 2019 and held it in 1 quarter.
  • Wealthspire Advisors (Maryland)'s Immune Design Corp. position peaked at $38K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.